Clinical Trial Update: Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating cardiac function in COPD patients treated with budesonide/formoterol (Symbicort) versus placebo. The study was terminated and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: TERMINATED | Results posted: 2017-06-14